Showing results (41-50 of 76) with videos related to

Sort By:
Pageof 8
Current Opinion in Lipidology|November 22, 2011
Intestinal sterol transporters and cholesterol absorption inhibitionHarry R Davis, Andrew M Tershakovec, Joanne E Tomassini, et al.
The American Journal of Cardiology|January 31, 2006
Striated muscle safety of ezetimibe/simvastatin (Vytorin)Michael H Davidson, Darbie Maccubbin, Michael Stepanavage, et al.
Clinical Therapeutics|June 22, 2012
Efficacy and tolerability of initial therapy with single-pill combination telmisartan/hydrochlorothiazide 80/25 mg in patients with grade 2 or 3 hypertension: a multinational, randomized, double-blind, active-controlled trialDingliang L Zhu, Harold Bays, Pingjin Gao, et al.
Vascular Health and Risk Management|June 14, 2013
Management of dyslipidemia and hyperglycemia with a fixed-dose combination of sitagliptin and simvastatinHelmut Steinberg, Matt S Anderson, Thomas Musliner, et al.
Current Medical Research and Opinion|November 8, 2016
Liraglutide 3.0 mg for weight management: weight-loss dependent and independent effectsHarold Bays, Xavier Pi-Sunyer, Joanna Uddén Hemmingsson, et al.
Cardiovascular Drugs and Therapy|April 5, 2021
Role of Bempedoic Acid in Clinical PracticeChristie M Ballantyne, Harold Bays, Alberico L Catapano, et al.
Journal of Clinical Lipidology|June 16, 2015
Safety and tolerability of extended-release niacin-laropiprant: Pooled analyses for 11,310 patients in 12 controlled clinical trialsJames McKenney, Harold Bays, Gilbert Gleim, et al.
Nutrition & Metabolism|August 18, 2011
Reduced viscosity Barley β-Glucan versus placebo: a randomized controlled trial of the effects on insulin sensitivity for individuals at risk for diabetes mellitusHarold Bays, Joy L Frestedt, Margie Bell, et al.
Diabetes Care|October 23, 2013
Effects of naltrexone sustained-release/bupropion sustained-release combination therapy on body weight and glycemic parameters in overweight and obese patients with type 2 diabetesPriscilla Hollander, Alok K Gupta, Raymond Plodkowski, et al.
Clinical Therapeutics|December 26, 2007
Effects of ezetimibe/simvastatin on lipoprotein subfractions in patients with primary hypercholesterolemia: an exploratory analysis of archived samples using two commercially available techniquesLeiv Ose, Robert Reyes, Amy O Johnson-Levonas, et al.
Pageof 8